| Recruiting | A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients Wi Primary Hypercholesterolemiia, Mixed Dyslipidemia | — | 2025-02-12 |
| Recruiting | A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junctio HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma | — | 2023-12-05 |
| Recruiting | DESTINY Breast Respond HER2-low Europe Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer | — | 2023-10-24 |
| Withdrawn | Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Primary Hypercholesterolemia, Mixed Dyslipidemia | — | 2023-09-01 |
| Completed | SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Hypercholesterolemia, Mixed Dyslipidemia | — | 2022-04-22 |
| Active Not Recruiting | Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia Hypercholesterolemia, Mixed Dyslipidemia | — | 2021-01-15 |
| Completed | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events Dyslipidemia, Cardiovascular Diseases, Hypercholesterolemia | — | 2020-03-17 |
| Completed | Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Cath Atrial Fibrillation | Phase 3 | 2017-03-21 |
| Completed | Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Co Atrial Fibrillation | Phase 3 | 2017-02-24 |
| Completed | Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe Venous Thromboembolism | — | 2016-04-06 |
| Terminated | The Confirmatory Olmesartan Plaque Regression Study Essential Hypertension, Carotid Plaque | Phase 4 | 2010-05-01 |
| Completed | Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure Hypertension | Phase 4 | 2010-04-01 |
| Completed | Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With M Metabolic Syndrome, Hypertension | Phase 3 | 2008-10-01 |
| Completed | Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Metabolic Syndrome, Hypertension | Phase 3 | 2008-08-01 |
| Terminated | Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Bloo Chronic Heart Failure, High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level | Phase 3 | 2008-06-01 |
| Completed | Isolated Systolic Hypertension in the Elderly and Very Elderly Isolated Systolic Hypertension | Phase 3 | 2003-07-01 |
| Completed | Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly Essential Hypertension | Phase 3 | 2003-06-01 |